COLM
Columbia Sportswear Company
COLM has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
COLM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
COLM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
COLM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $69.30 | -3.3% |
| Current | 16x | $71.64 | — |
| Forward | 17x | $71.64 | — |
| Fair | 18x | $83.30 | +16% |
| Expensive | 26x | $117 | +63% |
Historical ranges are pointers, not guarantees.
COLM's PE is in its cheap range at 16x. On analysts' estimates for next year's earnings, today's price would be 17x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
COLM Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for COLM, with profitability improving.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
COLM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.34 | -4.8% |
| Q3 2026 | $4.56 | +40% |
| Q2 2026 | $3.85 | -0.5% |
| Q1 2026 | $3.14 | -19% |
| Q4 2025 | $3.24 | -15% |
| Q3 2025 | $3.26 | -8.9% |
| Q2 2025 | $3.87 | +4% |
| Q1 2025 | $3.86 | -4.9% |
| Q4 2024 | $3.82 | -6.6% |
COLM has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
COLM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $962.6M | +2% |
| Q2 2026 | $614.4M | +1.5% |
| Q1 2026 | $779M | +0.1% |
| Q4 2025 | $1.1B | -2.4% |
| Q3 2025 | $943.4M | +1.3% |
| Q2 2025 | $605.2M | +6.1% |
| Q1 2025 | $778.5M | +1.1% |
| Q4 2024 | $1.1B | +3.5% |
COLM's revenue fell from its 2022 peak and has held roughly level since: $963M last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +4.3 points |
| Q2 2026 | 5% | +8.9 points |
| Q1 2026 | 5.4% | -0.6 points |
| Q4 2025 | 11% | -1.6 points |
| Q3 2025 | 7.1% | -4.9 points |
| Q2 2025 | -3.9% | +0.3 points |
| Q1 2025 | 6% | +0.2 points |
| Q4 2024 | 13% | +1.8 points |
COLM has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over COLM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
COLM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$333M | -$45.8M |
| Q2 2026 | $101.6M | +$147M |
| Q1 2026 | -$90M | -$42.4M |
| Q4 2025 | $596.8M | +8.6% |
| Q3 2025 | -$287.2M | -$87.7M |
| Q2 2025 | -$45.3M | -$34.4M |
| Q1 2025 | -$47.6M | -152% |
| Q4 2024 | $549.6M | -8.5% |
COLM has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
COLM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -318K shares |
| 1 year | -6.6% | -3.6M shares |
| 3 years | -16% | -10M shares |
| 5 years | -23% | -15.3M shares |
| Available history | -26% | -17.5M shares |
COLM has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50M |
| Q2 2026 | — |
| Q1 2026 | $150M |
| Q4 2025 | $29.4M |
| Q3 2025 | $40M |
| Q2 2025 | $30.3M |
| Q1 2025 | $101.4M |
| Q4 2024 | $86.9M |
COLM spent $229M buying back its own shares over the past year, down 11% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
COLM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
COLM has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
COLM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 92.5 | Overbought |
COLM's weekly RSI is 71 (overbought) and its Stochastic is 93 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
COLM PE vs Consumer Cyclical Sector
| Metric | COLM | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 13% below |
| PE % | 21 | 47 | 26 pts below |
COLM is trading at 16x earnings, a 13% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
COLM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 14% above |
| 20 week MA | $61.0 | 18% above |
| 50 week MA | $60.0 | 19% above |
| 100 week MA | $62.8 | 14% above |
| 200 week MA | $71.6 | 0.1% above |
COLM has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
COLM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $99.7 | $90.2 | -9.5% |
| 2021 | $90.2 | $93.8 | +4% |
| 2022 | $93.8 | $85.9 | -8.4% |
| 2023 | $85.9 | $79.5 | -7.4% |
| 2024 | $79.5 | $85.8 | +7.8% |
| 2025 | $85.8 | $55.6 | -35% |
| 2026 YTD | $55.6 | $71.6 | +29% |
COLM has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.